Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new entry for Revision: v3.6.6 was added to the Study Record History, replacing Revision: v3.6.5. This indicates a site release update applied to the ClinicalTrials.gov records.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, indicating an update to the page, and the previous revision v3.6.4 was removed from the visible history.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study's record history now includes a new Revision: v3.6.4 entry, replacing the previous Revision: v3.6.3 in the version list.SummaryDifference0.1%

- Check82 days agoChange DetectedThe record history now shows a new revision entry: v3.6.3, replacing the previous v3.6.1. This represents a minor metadata update to the study's record version on the ClinicalTrials.gov page.SummaryDifference0.1%

- Check89 days agoChange DetectedRecord history now includes a new release entry 'Revision: v3.6.1' and removes the prior 'Revision: v3.6.0'. This reflects a minor software version update in the page's release-tracking metadata.SummaryDifference0.1%

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.